Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR)

CUSIP: 92764N102

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
159,231,812
Total 13F shares
88,385,448
Share change
+2,390,719
Total reported value
$2,056,730,043
Put/Call ratio
67%
Price per share
$23.27
Number of holders
226
Value change
+$54,021,550
Number of buys
114
Number of sells
99

Quarterly Holders Quick Answers

What is CUSIP 92764N102?
CUSIP 92764N102 identifies VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) as of Q1 2023

As of 31 Mar 2023, Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) was held by 226 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 88,385,448 shares. The largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, BlackRock Inc., VANGUARD GROUP INC, Temasek Holdings (Private) Ltd, STATE STREET CORP, BAILLIE GIFFORD & CO, ALLIANCEBERNSTEIN L.P., Point72 Asset Management, L.P., Avidity Partners Management LP, and Bill & Melinda Gates Foundation. This page lists 227 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.